Giant Basal Cell Carcinoma Research Articles

Giant basal cell carcinoma (T3). Who is at risk?

Giant basal cell carcinomas can cause extensive local invasion and disfigurement. This study determines in whom giant basal cell carcinomas develop. Fifty patients with giant basal cell carcinomas (over 5 cm, T3) were compared with other groups of patients with small (< 2 cm, T1) or intermediate-sized (2-5 cm, T2) basal cell carcinomas. The patients were treated at the Mayo Clinic between August 1986 and December 1990. Characteristics that were more common in giant basal cell carcinomas than in smaller lesions were duration, patient neglect, recurrence after previous treatment, aggressive histologic pattern, and history of radiation exposure. Patients who have a basal cell carcinoma with an aggressive histologic subtype, a recurrence after previous treatment, a history of radiation exposure, or a history of neglect are at risk for giant basal cell carcinoma.

Shoulder girdle resection for giant basal cell carcinoma

Forequarter amputation may seem the only surgical option when a tumour of the scapula or its overlying soft tissues invades the bones of the shoulder joint. As illustrated in this case of giant basal cell carcinoma, shoulder girdle (Tikhor-Linberg) resection is occasionally, possible, thus preserving a functional arm.

Giant basal cell carcinoma with metastasis and secondary amyloidosis: report of case

Basal cell carcinoma of the skin is a slow growing relatively benign tumor usually located on the head and neck. Although rare, metastasis to lymph nodes or parenchymatous organs has been reported previously (1-9). We wish to add another case of metastasizing basal cell carcinoma of the skin, which presented certain unique features only rarely reported (1), namely complicating amyloidosis in the kidneys, the lymph nodes, the spleen and probably in the intestinal canal.